Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Cancer”

2,289 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,289 results

Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)Study completedNCT04209192
What this trial is testing

Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)

Who this might be right for
Urinary Tract InfectionsBladder CancerUrologic Surgical Procedures
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 75
Not applicableUnknownNCT03628092
What this trial is testing

Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

Who this might be right for
Vulvovaginal AtrophyGenitourinary Symptoms and Ill-Defined Conditions
Royal North Shore Hospital 70
Not applicableStudy completedNCT02203136
What this trial is testing

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 16
Not applicableUnknownNCT01814150
What this trial is testing

The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel

Who this might be right for
Metastatic Lung CancerMetastatic Breast CancerMetastatic Gastric Cancer+2 more
Gottfried Maya 200
Not applicableStudy completedNCT04605315
What this trial is testing

Indications and Outcomes in Kidney-ureteral Pediatric Lithiasis: Experience of Parma

Who this might be right for
Pediatric ALLStone, Urinary
Azienda Ospedaliero-Universitaria di Parma 70
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Not applicableLooking for participantsNCT06691776
What this trial is testing

Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)

Who this might be right for
Prostate CancerCervical CancerBladder Cancer+2 more
The Netherlands Cancer Institute 100
Not applicableLooking for participantsNCT06991868
What this trial is testing

Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)

Who this might be right for
NMIBCMIBCUTUC
Peking University First Hospital 300
Not applicableStudy completedNCT00772018
What this trial is testing

Quality of Life and Symptom Management in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
David Latini 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Not applicableUnknownNCT04577222
What this trial is testing

The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy

Who this might be right for
Prostate CancerErectile DysfunctionUrinary Incontinence
Rabin Medical Center 60
Early research (Phase 1)Ended earlyNCT05061537
What this trial is testing

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Renal Cell CancerMelanomaNon-Small-Cell Lung Cancer+7 more
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT00380029
What this trial is testing

Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
UNC Lineberger Comprehensive Cancer Center 27
Large-scale testing (Phase 3)Study completedNCT00315237
What this trial is testing

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Who this might be right for
Transitional Cell Carcinoma of the Urothelial TractBladder CancerBladder Neoplasms
Pierre Fabre Medicament 364
Not applicableUnknownNCT06347614
What this trial is testing

Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study

Who this might be right for
Prostate Cancer
Sun Yat-sen University 30
Not applicableUnknownNCT02292914
What this trial is testing

Prospective Analysis of Robot-Assisted Surgery

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+7 more
Instituto do Cancer do Estado de São Paulo 1,120
Testing effectiveness (Phase 2)Study completedNCT02343614
What this trial is testing

Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer

Who this might be right for
Non Muscle Invasive Bladder Cancer
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04561362
What this trial is testing

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Who this might be right for
Urinary Bladder NeoplasmTriple Negative Breast NeoplasmsHormone Receptor Positive, HER2-negative Neoplasms+5 more
BicycleTx Limited 329
Testing effectiveness (Phase 2)Active Not RecruitingNCT03459846
What this trial is testing

Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Who this might be right for
Urinary Bladder Neoplasms
AstraZeneca 154
Next Page